Medeca - Company finances
|
EUR
|
2018
From: 2018-09-25
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 13,643 | 259,975 | 4,329,964 | 1,273,643 | 1,454,272 | 2,294,614 | 2,194,805 | 2,643,131 |
| Profit before tax | 5,516 | 67,186 | - | - | 187,890 | 57,314 | 55,620 | 51,663 |
| Net profit | 5,240 | 63,827 | 323,471 | -131,454 | 176,499 | 46,422 | 46,611 | 43,200 |
| Equity | 7,740 | 71,567 | 431,497 | 242,807 | 178,952 | 53,174 | 99,785 | 63,346 |
| Liabilities | 3,417 | 127,655 | 2,179,077 | 2,086,666 | 1,720,198 | 1,572,340 | 2,522,084 | 3,225,585 |
| Non-current assets | 0 | 884 | 10,283 | 182,768 | 179,838 | 145,123 | 238,537 | 88,067 |
| Current assets | 11,157 | 198,110 | 2,600,291 | 2,146,705 | 1,719,312 | 1,480,391 | 2,383,332 | 3,200,864 |
| Total assets | 11,157 | 198,994 | 2,610,574 | 2,329,473 | 1,899,150 | 1,625,514 | 2,621,869 | 3,288,931 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 239 | 16,795 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +1805.6% | +1565.5% | -70.6% | +14.2% | +57.8% | -4.3% | +20.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 47.0% | 32.1% | 12.4% | -5.6% | 9.3% | 2.9% | 1.8% | 1.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 67.7% | 89.2% | 75.0% | -54.1% | 98.6% | 87.3% | 46.7% | 68.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 38.4% | 24.6% | 7.5% | -10.3% | 12.1% | 2.0% | 2.1% | 1.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 40.4% | 25.8% | - | - | 12.9% | 2.5% | 2.5% | 2.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 1.8 | 5.1 | 8.6 | 9.6 | 29.6 | 25.3 | 50.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 13,643 | 259,975 | 3,463,971 | 611,358 | 727,136 | 1,147,307 | 1,097,403 | 1,321,566 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medeca - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-06-17 | 2025-06-18 | 33.71 |
| 2025-02-18 | 2025-02-23 | 152.56 |
Medeca - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-21 | 1167.62 |
| 2025-12-18 | 2025-12-29 | 0.09 |
| 2025-09-14 | 2025-09-14 | 1629.45 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medeca, UAB (code 304923205) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €2.64M, up 20.4% year on year and 15.2% over two years. Net profit was €43.2K, while the net profit margin narrowed to 1.6% from 2.1% in 2024 and 2.0% in 2023, showing that profitability remained positive but modest relative to sales. Over the last three years, revenue moved from €2.29M in 2023 to €2.19M in 2024 and then recovered in 2025, while net profit stayed in a narrow range around €43K-€47K.
The balance sheet expanded further in 2025, with total assets reaching €3.29M, liabilities €3.23M and equity €63.3K. The equity base remained small compared with liabilities, indicating a highly leveraged structure. Asset turnover was 0.80x, ROA 1.3%, and revenue per employee €1.32M, with profit per employee €21.6K. The 2025 results point to growth in scale, but with thin margins and limited equity support.
The balance sheet expanded further in 2025, with total assets reaching €3.29M, liabilities €3.23M and equity €63.3K. The equity base remained small compared with liabilities, indicating a highly leveraged structure. Asset turnover was 0.80x, ROA 1.3%, and revenue per employee €1.32M, with profit per employee €21.6K. The 2025 results point to growth in scale, but with thin margins and limited equity support.